India's Pharmaceutical Exports Reach Nearly $29 Billion in FY26 Amid Steady Growth

Original: India’s pharma exports near $29 billion by February in FY26, maintain steady growth

Mint•Apr 4, 20261 min

In a Nutshell

India's pharmaceutical exports have reached nearly $29 billion by February in the financial year 2026, marking a 5% increase from the previous year. The sector, valued at approximately $60 billion, is expected to grow to $130 billion by 2030, driven by formulations, biologicals, vaccines, and Ayush products.

Key Points

01Pharmaceutical exports reached nearly $29 billion by February FY26.
02The sector grew by 5% compared to the same period last year.
03Projected growth to $130 billion by 2030.
04Exports for FY25 reached $30.47 billion, a 9.4% year-on-year increase.
05Growth driven by formulations, biologicals, vaccines, and Ayush products.

In-Article Ad

Full Summary

Indian pharmaceutical exports have shown resilience, reaching nearly $29 billion by February in the financial year 2026, reflecting a 5% growth compared to the same period in the previous year. K Raja Bhanu, Director General of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), noted that the sector is currently valued at approximately $60 billion and is projected to grow to $130 billion by 2030. The growth is attributed to strong demand for formulations, biologicals, vaccines, and Ayush products. In the previous financial year, exports reached $30.47 billion, marking a 9.4% increase year-on-year despite facing global pricing pressures and trade volatilities. This consistent growth highlights the pharmaceutical sector's ability to navigate challenges in the global market.

Key Figures

$29 billion

Pharmaceutical exports by February FY26

5%

Growth compared to the same period last year

$30.47 billion

Exports for FY25

9.4%

Year-on-year growth for FY25

In-Article Ad

Why It Matters

The growth in pharmaceutical exports can lead to increased job opportunities and economic stability in the sector, benefiting workers and companies involved in production and distribution.

Who is affected

Pharmaceutical manufacturers, workers in the sector, and related industries.

What to know

Stakeholders in the pharmaceutical industry should continue to innovate and adapt to global market demands to sustain growth.

FAQ

The current value of India's pharmaceutical sector is approximately $60 billion.

The main products contributing to the growth in exports include formulations, biologicals, vaccines, and Ayush products.

✦